Who Paid My Doc
Axumin
Drug Diagnostic Imaging
NDC 69932-001-50
General payments
$625,593
Research payments
$3,941,540
Through program year 2025, $625,593 in general payments and $3,941,540 in research payments were reported against Axumin (Diagnostic Imaging).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $22,675 | 6 |
| 2025 | Research | $309,989 | 60 |
| 2024 | General | $65,245 | 9 |
| 2024 | Research | $835,041 | 120 |
| 2023 | General | $244,423 | 2,380 |
| 2023 | Research | $410,832 | 44 |
| 2022 | General | $293,249 | 3,753 |
| 2022 | Research | $2,385,678 | 181 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
6,148 general · 405 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.